ANZCNS 6th Annual Scientific Meeting
(Wednesday 9th - Friday 11th August 2017)
Brisbane Convention & Exhibition Centre, South Brisbane
|27th March 2017||Abstract submission opens
|26th June 2017||Abstract submission closes
Early bird registration closes
Accommodation bookings are subject to availability from this date
|24th July 2017||All registration closes (no on-site registration)|
We warmly welcome you to this year’s annual scientific meeting.
Deborah L. Renaud, MD, is a neurometabolic specialist focusing on neurologic manifestations of inherited metabolic disorders, with a particular interest in inherited leukoencephalopathies. She is the Director of the Neurometabolic Clinic and Leukodystrophy Program at the Mayo Clinic in Rochester, MN, which provide comprehensive evaluation and care for adults and children with neurometabolic disorders and inherited leukoencephalopahy. She also co-directs the Mayo Clinic Peroxisomal Disorders Program, a multidisciplinary program for patients with peroxisomal disorders with special emphasis on boys with X-linked adrenoleukodystrophy (X-ALD) as well as men and women with adrenomyeloneuropathy (AMN).
Dr. Renaud is a Fellow of the Royal College of Physicians and Surgeons of Canada in both Pediatrics and Neurology. She is a Diplomat of the American Board of Pediatrics and is certified in Neurology with Special Qualifications in Child Neurology by the American Board of Psychiatry and Neurology. More recently, she became certified in Medical Biochemical Genetics by the American Board of Medical Genetics and Genomics. Dr. Renaud is a graduate of the University of Western Ontario where she studied Biology and received her M.D. degree. She completed residency training in Pediatrics and Pediatric Neurology at the Children’s Hospital of Eastern Ontario in Ottawa and Hospital for Sick Children in Toronto. As a Clinical and Research Fellow in Genetic Metabolic Disorders at Hospital for Sick Children in Toronto, she completed a research fellowship in the Neurometabolics Laboratory.
Marc C. Patterson, MD, FRACP, FAAN, FANA, was born and educated in Australia, and trained in neurology, child neurology and neurometabolic disease at the University of Queensland, at Mayo Clinic, and at NINDS/NIH, the last mentioned under the guidance of Roscoe Brady, MD. He is currently Professor of Neurology, Pediatrics and Medical Genetics, and Chair of the Division of Child and Adolescent Neurology at Mayo Clinic, He was Director of the Child Neurology Training program at Mayo 2008-2016), and had previously served as Professor and Director of Pediatric Neurology at Columbia University in New York (2001-2007). He has served as a member of the Neurology topic advisory group for revision of the ICD-10 of the World Health Organization, the Committee on Adverse Effects of Vaccines for the Institute of Medicine, and leads the Education Core of the NIH-funded Lysosomal Disease Network.
He has served in a number of positions in the Child Neurology Society, American Academy of Neurology, American Board of Psychiatry and Neurology and American Neurological Association. Professor Patterson has served on the editorial board of Neurology, on the oversight committee of Annals of Neurology and is currently an Editor for the Journal of Inherited Metabolic Disease. He became Editor-in Chief of the Journal of Child Neurology on January 1st, 2014, and subsequently Editor-in-Chief of its open-access sister journal, Child Neurology Open.
His research and practice has focused on rare diseases in children, including multiple sclerosis and neurometabolic disorders in general, with special interests in Niemann-Pick disease, type C, other lysosomal diseases (including glycoproteinoses), mitochondrial cytopathies and congenital disorders of glycosylation, areas in which he has published more than 200 peer-reviewed papers and book chapters. He has presented widely through the United States and internationally, both to professional and lay organizations. Dr Patterson has received funding support from NIH, industry and private foundations.Local and National speakers include:
Nick Smith, WCH Adelaide
Linda Richards, QBI, University of Queensland
David Reutens, CAI, University of Queensland
Alex Lehn, MMRI, MRI-UQThe Program Committee are currently finalizing the conference program and program updates will be available shortly.
Located in the heart of Brisbane’s arts and entertainment precinct, Rydges South Bank Brisbane accommodation has a wide range of attractions on its doorstep including the South Bank Parklands and the Brisbane Convention & Exhibition Centre.
The rate is $259 per room per night.
Complimentary wi-fi is included for all group guests staying in house.
Rates are applicable for up to 2 adults; extra adults charged at $60 per night.
Daily full buffet breakfast is available for $39pp. May be purchased directly with the hotel during your stay.
Cancellations or reduction of room nights received after 30 days prior to the 9th August will incur a charge to equal 1 nights accommodation per booking cancelled.
Cancellations or amendments to existing bookings after 14days prior to the 9th August will incur a charge equivalent to the full duration of the stay.
No shows will be charged for the duration of the booking.
|Fee Type||Early Fee (Payment by 26th June 2017)||Standard Fee|
|ANZCNS Ordinary Member (Consultant Physician)||$650||$850|
|ANZCNS Trainee Member (Medical, Postgraduate)||$300||$450|
|ANZCNS Retired Member (Physician)||$300||$300|
|ANZCNS Associate Member (Allied Health, Nursing, Neurophysiology)||$300||$450|
|Non Member Consultant Physician||$800||$1000|
|Non Member Trainee (Medical, Postgraduate)||$450||$600|
|Non Member Retired Physician||$300||$300|
|Non Member Special Groups (Allied Health, Nursing, Neurophysiology)||$450||$600|
|Medical Student (Undergraduate)||$200||$200|
|All other professions||$800||$1000|
|Concession (Allied Health, Nursing, Neurophysiology)||$200||$200|